ArticleCancer medicine2025

Heterogeneity of Checkpoint Inhibitor-Associated Pneumonitis: A Multicenter Study on Inflammatory Subtypes and Clinical Outcomes.

Tingyue Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.